VIRACTA THERAPEUTICS

Viracta is a precision oncology company targeting virus-associated malignancies. Viracta's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphoma. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.

VIRACTA THERAPEUTICS

Social Links:

Twitter

Industry:

Biopharma Biotechnology Medical Pharmaceutical Therapeutics

Founded:

2007-01-01

Address:

Cardiff By The Sea, California, United States

Country:

United States

Website Url:

http://www.viracta.com

Total Employee:

11+

Status:

Active

Contact:

(858)400-8470

Email Addresses:

[email protected]

Total Funding:

194.9 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache Wordpress Plugins

Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

Current Advisors List

roger-pomerantz_image

Roger Pomerantz Chair Of The Board Of Directors @ Viracta Therapeutics
Board_member
2020-06-01

patrick-soon-shiong_image

Patrick Soon-Shiong Board Of Director @ Viracta Therapeutics
Board_member

frederick-dotzler_image

Frederick Dotzler Board @ Viracta Therapeutics
Board_member

steve-rubino_image

STEVE RUBINO Independent Member, Board of Directors @ Viracta Therapeutics
Board_member
2021-03-01

michael-huang_image

Michael Huang Board of Directors @ Viracta Therapeutics
Board_member

Current Employees Featured

ronald-berenson_image

Ronald Berenson
Ronald Berenson Co-founder & CEO @ Viracta Therapeutics
Co-founder & CEO

not_available_image

Lisa Rojkjaer
Lisa Rojkjaer Chief Medical Officer & MD @ Viracta Therapeutics
Chief Medical Officer & MD
2020-05-01

not_available_image

George Stamatoyannopoulos
George Stamatoyannopoulos Co-Founder and Director @ Viracta Therapeutics
Co-Founder and Director

ivor-royston_image

Ivor Royston
Ivor Royston CEO & President @ Viracta Therapeutics
CEO & President
2015-01-01

douglas-v-faller_image

Douglas V Faller
Douglas V Faller Scientific Founder; Chair, Scientific Advisory Board @ Viracta Therapeutics
Scientific Founder; Chair, Scientific Advisory Board
2018-01-01

not_available_image

George Hillman
George Hillman COO, VP & Co-Founder @ Viracta Therapeutics
COO, VP & Co-Founder

dan-chevallard_image

Dan Chevallard
Dan Chevallard Chief Operating Officer and Chief Financial Officer @ Viracta Therapeutics
Chief Operating Officer and Chief Financial Officer

Founder

douglas-v-faller_image

Douglas V Faller

not_available_image

George Hillman

not_available_image

George Stamatoyannopoulos

ivor-royston_image

Ivor Royston

ronald-berenson_image

Ronald Berenson

Stock Details

Company's stock symbol is NASDAQ:VIRX

Acquisitions List

Date	Company	Article	Price
2020-11-30	Sunesis Pharmaceuticals	Sunesis Pharmaceuticals acquired by Viracta Therapeutics	N/A

Investors List

oxford-finance-corporation_image

Key Employee Changes

Date	New article
2020-03-25	Viracta Announces Appointment of Lisa Rojkjaer, MD, as Chief Medical Officer

Official Site Inspections

http://www.viracta.com Semrush global rank: 3.25 M Semrush visits lastest month: 5.08 K

Host Informations
Whois Informations

Loading ...